Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
NASDAQ:BNR
Price:
0.807 USD
6.38%
Market Closed
Updated:
May 6, 2024
Burning Rock Biotech Ltd
Research & Development
|
Burning Rock Biotech Ltd
Research & Development Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Research & Development
-¥347m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Research & Development
-¥10.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Research & Development
-¥2.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Research & Development
-¥1.1B
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Research & Development
-¥895.2m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-83%
|
CAGR 10-Years
N/A
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Research & Development
-¥168.2m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Research & Development?
Research & Development
-347m
CNY
-347m
CNY
Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's Research & Development amounts to -347m CNY.
What is Burning Rock Biotech Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-27%
-27%
Over the last year, the Research & Development growth was 18%. The average annual Research & Development growth rates for Burning Rock Biotech Ltd have been -10% over the past three years , -27% over the past five years .
You don't have any saved screeners yet
